Selection and characterisation of affibody molecules inhibiting the interaction between Ras and Raf in vitro

N Biotechnol. 2010 Dec 31;27(6):766-73. doi: 10.1016/j.nbt.2010.07.016. Epub 2010 Jul 30.

Abstract

Development of molecules with the ability to selectively inhibit particular protein-protein interactions is important in providing tools for understanding cell biology. In this work, we describe efforts to select small Ras- and Raf-specific three-helix bundle affibody binding proteins capable of inhibiting the interaction between H-Ras and Raf-1, from a combinatorial library displayed on bacteriophage. Target-specific variants with typically high nanomolar or low micromolar affinities (K(D)) could be selected successfully against both proteins, as shown by dot blot, ELISA and real-time biospecific interaction analyses. Affibody molecule variants selected against H-Ras were shown to bind epitopes overlapping each other at a site that differed from that at which H-Ras interacts with Raf-1. In contrast, an affibody molecule isolated during selection against Raf-1 was shown to effectively inhibit the interaction between H-Ras and Raf-1 in a dose-dependent manner. Possible intracellular applications of the selected affibody molecules are discussed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Epitopes / metabolism
  • Genes, ras*
  • Humans
  • Molecular Sequence Data
  • Protein Binding
  • Proto-Oncogene Proteins c-raf / genetics
  • Proto-Oncogene Proteins c-raf / metabolism*
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / metabolism*
  • Sequence Alignment
  • ras Proteins / genetics
  • ras Proteins / metabolism*

Substances

  • Epitopes
  • Recombinant Fusion Proteins
  • Proto-Oncogene Proteins c-raf
  • ras Proteins